Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

被引：0
|
作者：
Tjalf Ziemssen
Michael Lang
Stephan Schmidt
Holger Albrecht
Luisa Klotz
Judith Haas
Christoph Lassek
Stefan Lang
Veronika E. Winkelmann
Benjamin Ettle
Ulf Schulze-Topphoff
机构：
[1] University of Technology,Center of Clinical Neuroscience, Neurological University Clinic Carl Gustav Carus
[2] NeuroPoint Patient Academy and Neurological Practice,Department of Neurology
[3] Health Center St. Johannes,Center for Multiple Sclerosis
[4] Neurological Practice,undefined
[5] University Hospital Münster,undefined
[6] Jewish Hospital Berlin,undefined
[7] Neurological Practice,undefined
[8] Kassel and Vellmar,undefined
[9] Scientific and Medical Writing,undefined
[10] Novartis Pharma GmbH,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Relapsing–remitting multiple sclerosis; Fingolimod; Real-world; Safety; Effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3276 / 3285
页数：9
相关论文
共 50 条
  • [21] The effectiveness of fingolimod in a Portuguese real-world population
    Correia, I.
    Batista, S.
    Marques, I. B.
    Sousa, M.
    Ferreira, R.
    Nunes, C.
    Macario, M. C.
    Sousa, L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 6 : 41 - 48
  • [22] The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
    Biernacki, Tamas
    Sandi, Daniel
    Fuvesi, Judit
    Fricska-Nagy, Zsanett
    Kincses, Tamas Zsigmond
    Acs, Peter
    Rozsa, Csilla
    Dobos, Eniko
    Cseh, Botond
    Horvath, Laszlo
    Nagy, Zsuzsanna
    Csanyi, Attila
    Kovacs, Krisztina
    Csepany, Tunde
    Vecsei, Laszlo
    Bencsik, Krisztina
    PLOS ONE, 2022, 17 (04):
  • [23] Real-world data confirm long-term effectiveness of bronchial thermoplasty
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (10) : 548 - 548
  • [24] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
    Chaparro, Maria
    Baston-Rey, Iria
    Fernandez-Salgado, Estela
    Gonzalez Garcia, Javier
    Ramos, Laura
    Diz-Lois Palomares, Maria Teresa
    Arguelles-Arias, Federico
    Iglesias Flores, Eva
    Cabello, Mercedes
    Rubio Iturria, Saioa
    Nunez Ortiz, Andrea
    Charro, Mara
    Ginard, Daniel
    Duenas Sadornil, Carmen
    Merino Ochoa, Olga
    Busquets, David
    Iyo, Eduardo
    Gutierrez Casbas, Ana
    Ramirez de la Piscina, Patricia
    Maia Bosca-Watts, Marta
    Arroyo, Maite
    Jose Garcia, Maria
    Hinojosa, Esther
    Gordillo, Jordi
    Martinez Montiel, Pilar
    Velayos Jimenez, Benito
    Quilez Ivorra, Cristina
    Vazquez Moron, Juan Maria
    Maria Huguet, Jose
    Gonzalez-Lama, Yago
    Munagorri Santos, Ana Isabel
    Manuel Amo, Victor
    Dolores Martin-Arranz, Maria
    Bermejo, Fernando
    Martinez Cadilla, Jesus
    Rubin de Celix, Cristina
    Fradejas Salazar, Paola
    Lopez San Roman, Antonio
    Jimenez, Nuria
    Garcia Lopez, Santiago
    Figuerola, Anna
    Jimenez, Itxaso
    Martinez Cerezo, Francisco Jose
    Taxonera, Carlos
    Varela, Pilar
    de Francisco, Ruth
    Monfort, David
    Molina Arriero, Gema
    Hernandez Camba, Alejandro
    Javier Garcia-Alonso, Francisco
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736
  • [25] Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan
    Takeuchi, Tsutomu
    Hashimoto, Hideyuki
    Matsumoto, Mika
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 746 - 754
  • [26] Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
    Levra, Stefano
    Guida, Giuseppe
    Sprio, Andrea Elio
    Crosa, Flavio
    Ghio, Paolo Carlo
    Bertolini, Francesca
    Carriero, Vitina
    Albera, Carlo
    Ricciardolo, Fabio Luigi Massimo
    BIOMEDICINES, 2022, 10 (12)
  • [27] Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting
    Martin, Peter
    Barr, Paul
    Kahl, Brad S.
    Pathak, Ashutosh
    BLOOD, 2016, 128 (22)
  • [28] Long-term safety experience with bendamustine for injection in a real-world setting
    Martin, Peter
    Barr, Paul M.
    James, Leonard
    Pathak, Ashutosh
    Kahl, Brad
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 647 - 650
  • [29] Real-World Effectiveness and Safety Of Infliximab In The Treatment Of Rheumatoid Arthritis Over 5 Years: The Canadian Experience.
    Choquette, Denis
    Bensen, William
    Chow, Andrew
    Kelsall, John T.
    Sheriff, Maqbool K.
    Rodrigues, Jude F.
    Rampakakis, Emmanouil
    Sampalis, John S.
    Shawi, May
    Nantel, Francois
    Otawa, Susan M.
    Lehman, Allen J.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S207 - S208
  • [30] Real-world data from over 10 years in the TYSABRI® Observational Program: long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients
    Kappos, L.
    Butzkueven, H.
    Spelman, T.
    Trojano, M.
    Wiendl, H.
    Jiang, X.
    Kasliwal, R.
    Campbell, N.
    Ho, P. -R.
    Licata, S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 489 - 489
12345